Replies to post #16232 on Cannabix Technologies Inc (BLOZF)

[LongNDeep]

Isn't Bthcf trying to identify 17 different medical diseases? Each one having its own protocols to prove out...my point is...that's a lot more hurdles than Blozf having only the thc hurdle. I own a lot of both stocks, but realistically think Blozf will hit pay dirt first. Both stocks are undervalued and I am long in both.

[LongNDeep]

Breathtec’s entry into a licensing agreement will further investigation and advance development of NA-NOSE disease detection capabilities for the detection of the following indications from exhaled breath: Streptococcus; Methicillin resistant (MRSA); Staphylococcus; Enterococcus; Vancomycin resistant (VRE); Pneumococcus; Hemophilus influenza (HiB); Chickenpox; and the common cold. The testing of the novel ‘NA-NOSE’ prototypes will be carried out in three separate trials:

Outpatient clinic strep throat study.
Hospital inpatient MRSA and lower respiratory infection study.
2nd outpatient clinic viral infection respiratory infection study.

Sorry I can't find which article mentions how many diseases Bthcf will look for...there is many listed above.